Concepedia

Sarah Kopecky‐Bromberg

SK

Statistics

Publications

3

Citations

216

H-Index

3

Active since

2017

Affiliations

AbbVie (United States)(Current)

Sarah Kopecky‐Bromberg is an author at AbbVie (United States) specializing in antiviral therapy, viral hepatitis treatment, and pharmacotherapy.

Publications per year

2017–2019

3

Publications

3

Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct‐acting antiviral treatment failure

Fred Poordad, Stanislas Pol, Armen Asatryan et al. · Hepatology · 2017 · 139 citations · Full text

, , +17

Glecaprevir/Pibrentasvir in patients with chronic <scp>HCV</scp> genotype 3 infection: An integrated phase 2/3 analysis

Steven L. Flamm, David Mutimer, Armen Asatryan et al. · Journal of Viral Hepatitis · 2018 · 41 citations · Full text

, , +17

Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or older

Graham R. Foster, Tarik Asselah, Sarah Kopecky‐Bromberg et al. · PLoS ONE · 2019 · 36 citations · Full text

, , +17

1–3 of 3